Xiaoming Chen
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Screening Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Patients After Tyrosine Kinase Inhibitor Plus PD-1/PD-L1 Antibody Therapy: A Multicenter Retrospective Study.
Journal: Journal of hepatocellular carcinoma
Published: February 27, 2025
Drug-eluting beads bronchial arterial chemoembolization in advanced and standard treatment-refractory/ineligible non-small cell lung cancer.
Journal: Quantitative imaging in medicine and surgery
Published: August 25, 2024
Prognostic model for unresectable hepatocellular carcinoma treated with dual PD-1 and angiogenesis blockade therapy.
Journal: Journal for immunotherapy of cancer
Published: January 04, 2024
Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 01, 2022
Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study.
Journal: Journal of cancer research and clinical oncology
Published: July 10, 2021
A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression.
Journal: Liver cancer
Published: November 27, 2020
Advances and Challenges of Local Thermal Ablation in Non-small Cell Lung Cancer
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: February 26, 2020
Impact of Hydrogel Elasticity and Adherence on Osteosarcoma Cells and Osteoblasts.
Journal: Advanced healthcare materials
Published: February 20, 2020
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial.
Journal: The Lancet. Oncology
Published: September 03, 2019
MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.
Journal: Journal of cellular biochemistry
Published: April 07, 2019
Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study.
Journal: OncoTargets and therapy
Published: June 22, 2018
Last Updated: 09/26/2026